Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04903353
PHASE4

Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole

Sponsor: Vanderbilt University Medical Center

View on ClinicalTrials.gov

Summary

This study aims to compare two FDA approved medications (aripiprazole and risperidone) for the treatment of behavioral dysregulation in children with autism spectrum disorders. This trial, done in the context of routine clinical care, will seek to evaluate whether aripiprazole or risperidone is associated with more weight gain in children.

Key Details

Gender

All

Age Range

Any - 17 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2022-02-01

Completion Date

2025-12-01

Last Updated

2026-10-05

Healthy Volunteers

Yes

Interventions

DRUG

Comparison of Risperidone and Aripiprazole

Comparing two FDA approved medications for treatment of irritability in autism

Locations (1)

Division of Developmental Medicine

Nashville, Tennessee, United States